Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes

Diabetes Care

Volumn 31, Issue 8, 2008, Pages 1585-1589

  Gallego, Patricia H ^a   Craig, Maria E ^a,b,c   Duffin, Anthony C ^a   Bennetts, Bruce ^a   Jenkins, Alicia J ^d   Hofer, Sabine ^e   Lam, Albert ^a   Donaghue, Kim C ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; PARAOXON; PHENYLACETIC ACID; ARGININE; ARYLDIALKYLPHOSPHATASE; GLUTAMINE; LEUCINE; METHIONINE; PON1 PROTEIN, HUMAN;

ADOLESCENT; AMINO ACID SUBSTITUTION; APONEUROSIS; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; FASCIA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYDROLYSIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK REDUCTION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; AUSTRALIA; CAUCASIAN; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; ENZYMOLOGY; GENETICS; PATHOLOGY; PLANTAR FASCIITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARGININE; ARYLDIALKYLPHOSPHATASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASCIITIS, PLANTAR; FEMALE; GLUTAMINE; HUMANS; LEUCINE; MALE; METHIONINE; NEW SOUTH WALES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 49649105050     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2236     Document Type: Article

References (25)

1. Ferretti G, Bacchetti T, Busni D, Rabini RA, Curatola G: Protective effect of para- oxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. J Clin Endocrinol Metab 89:2957-2962, 2004
2. Kennedy AL, Lyons TJ: Glycation, oxidation, and lipoxidation in the development of diabetic complications. Metabolism 46: 14-21, 1997
3. Jenkins AJ, Rowley KG, Lyons TJ, Best JD, Hill MA, Klein RL: Lipoproteins and diabetic microvascular complications. Curr Pharm Des 10:3395-3418, 2004
4. James VJ, Delbridge L, McLennan SV, Yue DK: Use of X-ray diffraction in study of human diabetic and aging collagen. Diabetes 40:391-394, 1991
5. Duffin AC, Lam A, Kidd R, Chan AKF, Donaghue KC: Ultrasonography of plantar soft tissues thickness in young people with diabetes. DiabetMed 19:1009-1013, 2002
6. Craig ME, Duffin AC, Gallego PH, Lam A, Cusumano J, Hing S, Donaghue K: Plantar fascia thickness, a measure of tissue gly- cation, predicts the development of complications in adolescents with type 1 diabetes. Diabetes Care In press
7. Mackness MI, Mackness B, Durrington PN: Paraoxonase and coronary heart disease. Atheroscler Suppl 3:49-55, 2002
8. Kao Y, Donaghue KC, Chan A, Bennetts BH, Knight J, Silink M: Paraoxonase genecluster is a genetic marker for early micro- vascular complications in T1DM. Diabet Med 19:212-215, 2002
9. Hofer SE, Bennetts B, Chan AK, Holloway B, Karschimkus C, Jenkins AJ, Silink M, Donaghue KC: Association between PON 1 polymorphisms, PON activity and diabetes complications. J Diabetes Complications 20:322-328, 2006
10. Humbert R, Adler DA, Disteche CM, Has- sett C, Omiecinski CJ, Furlong CE: The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73-76, 1993
11. Kordonouri O, James RW, Bennetts B, Chan A, Kao YL, Danne T, Silink M, Donaghue K: Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus. Metabolism 50:657-660, 2001
12. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM: Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic ret- inopathy and nephropathy in the DCCT and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 54:3103-3111, 2005
13. Yu Y, Thorpe SR, Jenkins AJ, Shaw JN, Sochaski MA, McGee D, Aston CE, Orchard TJ, Silvers N, Peng YG, McKnight JA, Baynes JW, Lyons TJ: Advanced glycation end-products and methionine sul- phoxide in skin collagen of patients with T1DM. Diabetologia 49:2488-2498, 2006
14. Kao YL, Donaghue K, Chan A, Knight J, Silink M: A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM. J Clin Endocrinol Metab 83:2589-2592, 1998
15. Araki S, Makita Y, Canani L, Ng D, Warram JH, Krolewski AS: Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus. Diabetologia 43: 1540 -1543, 2000
16. Aviram M, Rosenblat M: Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 16:393-399, 2005
17. Garin MC, James RW, DussoixP, Blanche H, Passa P, Froguel P, Ruiz J: Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62-66, 1997
18. Khersonsky O, Tawfik DS: Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry 44:6371-6382, 2005
19. Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE: Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 11:77-84, 2001
20. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN: Serum paraoxo- nase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15:1812-1818, 1995
21. Mackness MI, Durrington PN, Mackness MI, Durrington PN: HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 115:243-253, 1995
22. James RW, Leviev I, Ruiz J, Passa P, Froguel P, Garin MC, James RW, Leviev I, Ruiz J, Passa P, Froguel P, Garin MC: Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 49:1390 -1393, 2000
23. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the paraoxonase gene associated with variation in plasma li- poproteins in a genetic isolate. Arterioscler Thromb Vasc Biol 15:89-95, 1995
24. Duffin AC, Donaghue KC, Potter M, McInnes A, Chan AK, King J, Howard NJ, Silink M: Limited joint mobility in the hands and feet ofadolescents with T1DM. Diabet Med 16:125-130, 1999
25. Wall JR, Harkness MA, Crawford A: Ultrasound diagnosis of plantar fasciitis. Foot Ankle 14:465-470, 1993